Selective Disruption of the Cerebral Neocortex in Alzheimer's Disease
暂无分享,去创建一个
Michael W. Weiner | Anders M. Dale | Mert R. Sabuncu | Bruce Fischl | David H. Salat | Reisa A. Sperling | Martin Reuter | Christopher P. Hess | Christopher D. Anderson | Rahul S. Desikan | Nicholas J. Schmansky | Jonathan Rosand | A. Dale | M. Weiner | T. Kemper | R. Desikan | R. Sperling | D. Salat | B. Fischl | M. Sabuncu | C. Hess | H. Cabral | N. Schmansky | A. Biffi | J. Rosand | M. Reuter | C. Anderson | Thomas L. Kemper | Alessandro Biffi | Howard J. Cabral
[1] R. Petersen. Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.
[2] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[3] C. Jack,et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.
[4] A. McKinney,et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease , 2010 .
[5] Pierrick Bourgeat,et al. Relationship between Atrophy and Beta-Amyloid Deposition in Normal Elderly, Mild Cognitive Impairment and Alzheimer's Disease , 2010, Alzheimer's & Dementia.
[6] Kiralee M. Hayashi,et al. Dynamics of Gray Matter Loss in Alzheimer's Disease , 2003, The Journal of Neuroscience.
[7] Nick C Fox,et al. Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] F. Sanides. COMPARATIVE ARCHITECTONICS OF THE NEOCORTEX OF MAMMALS AND THEIR EVOLUTIONARY INTERPRETATION * , 1969 .
[9] R. Woods,et al. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. , 2001, Cerebral cortex.
[10] P. Yakovlev. MOTILITY, BEHAVIOR AND THE BRAIN*: STEREODYNAMIC ORGANIZATION AND NEURAL CO‐ORDINATES OF BEHAVIOR , 1948, The Journal of nervous and mental disease.
[11] R. Woods,et al. Cortical Thinning in Cingulate and Occipital Cortices in First Episode Schizophrenia , 2005, Biological Psychiatry.
[12] Arnold B. Scheibel,et al. Neurobiology of higher cognitive function , 1990 .
[13] A. Nappi,et al. Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .
[14] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[15] J. Morrison,et al. Life and death of neurons in the aging brain. , 1997, Science.
[16] Alan C. Evans,et al. Structural Insights into Aberrant Topological Patterns of Large-Scale Cortical Networks in Alzheimer's Disease , 2008, The Journal of Neuroscience.
[17] P. C. Murphy,et al. Cerebral Cortex , 2017, Cerebral Cortex.
[18] P. Yakovlev. Motility, behavior, and the brain. , 1946, Abstracts and translations from the science library. Institute of Living.
[19] M. Mesulam,et al. From sensation to cognition. , 1998, Brain : a journal of neurology.
[20] Anders M. Dale,et al. Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.
[21] Gina N. LaRossa,et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans , 2006, Annals of neurology.
[22] B. Miller,et al. Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.
[23] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[24] G. V. Van Hoesen,et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.
[25] A M Dale,et al. Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[26] D. Holtzman,et al. Plaque‐associated disruption of CSF and plasma amyloid‐β (Aβ) equilibrium in a mouse model of Alzheimer's disease , 2002, Journal of neurochemistry.
[27] Cindee M. Madison,et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. , 2009, Brain : a journal of neurology.
[28] H. Soininen,et al. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. , 2006, Brain : a journal of neurology.
[29] C. Rowe,et al. Relationship between atrophy and β‐amyloid deposition in Alzheimer disease , 2010, Annals of neurology.
[30] S Ourselin,et al. β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia , 2010, Neurology.
[31] A. Dale,et al. Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.
[32] P. Thompson,et al. PET of brain amyloid and tau in mild cognitive impairment. , 2006, The New England journal of medicine.
[33] O. Sporns,et al. Mapping the Structural Core of Human Cerebral Cortex , 2008, PLoS biology.
[34] Bruce Fischl,et al. Highly accurate inverse consistent registration: A robust approach , 2010, NeuroImage.
[35] M Haupt,et al. [Clinical diagnosis of Alzheimer's disease]. , 1988, Deutsche medizinische Wochenschrift.
[36] Clifford R. Jack,et al. Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage , 2008, NeuroImage.
[37] M. Albert,et al. MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD , 2008, Neurology.
[38] Keith A. Johnson,et al. Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia , 2009, Neuron.
[39] Benjamin J. Shannon,et al. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.
[40] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[41] M. Greicius,et al. Resting-state functional connectivity reflects structural connectivity in the default mode network. , 2009, Cerebral cortex.
[42] M. Mesulam. Neuroplasticity Failure in Alzheimer's Disease Bridging the Gap between Plaques and Tangles , 1999, Neuron.
[43] C. Jack,et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. , 2007, Brain : a journal of neurology.
[44] A. Dale,et al. High‐resolution intersubject averaging and a coordinate system for the cortical surface , 1999, Human brain mapping.
[45] D. Holtzman,et al. Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease. , 2002, Journal of neurochemistry.
[46] Anders M. Dale,et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.
[47] A. W. Toga,et al. Early cortical change in Alzheimer's disease detected using cortical pattern matching and a disease-specific population-based brain atlas , 2000, NeuroImage.
[48] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[49] Keith A. Johnson,et al. Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease , 2009, The Journal of Neuroscience.
[50] Akram Bakkour,et al. The cortical signature of prodromal AD , 2009, Neurology.
[51] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[52] J. Winn,et al. Brain , 1878, The Lancet.
[53] Y. Pi. Motility, behavior, and the brain. , 1946 .
[54] M. Greicius,et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.
[55] J. Morrison,et al. The aging brain: morphomolecular senescence of cortical circuits , 2004, Trends in Neurosciences.
[56] A. Fagan,et al. APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging , 2010, Annals of neurology.
[57] C. Jack,et al. MRI correlates of neurofibrillary tangle pathology at autopsy , 2008, Neurology.
[58] D. Schacter,et al. The Brain's Default Network , 2008, Annals of the New York Academy of Sciences.
[59] R. Petersen,et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.
[60] H. Braak,et al. Neuropathology of Alzheimer’s Disease , 2004 .
[61] G. Frisoni,et al. In vivo mapping of amyloid toxicity in Alzheimer disease , 2009, Neurology.
[62] Keith A. Johnson,et al. Disruption of Functional Connectivity in Clinically Normal Older Adults Harboring Amyloid Burden , 2009, The Journal of Neuroscience.
[63] Michael Weiner,et al. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease , 2009, Annals of neurology.
[64] Janice E. Knoefel,et al. Clinical neurology of aging , 1985 .
[65] David A Wolk,et al. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease , 2010, Proceedings of the National Academy of Sciences.
[66] J. Morris,et al. The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals , 2008, Cerebral cortex.